Overview

Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
At one site, patients participating in the Corona main study are asked to participate in the PET-substudy. Before and 6 months after study medication is started a Positron Emission Tomography (PET-scan) is performed to study the effect of rosuvastatin in Chronic Heart Failure on myocardial perfusion (reserve)
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Rosuvastatin Calcium